Kingdon Capital Management's Ownership in enVVeno Medical Corporation


2025-09-09SEC Filing SCHEDULE 13G (0000919574-25-005609)

Kingdon Capital Management, L.L.C., along with M. Kingdon Offshore Master Fund L.P., Kingdon GP, LLC, and Mark Kingdon, have filed a Schedule 13G indicating their ownership in enVVeno Medical Corporation. Kingdon Capital Management, L.L.C. owns 7.1% of the Common Stock, amounting to 1,359,261 shares, while M. Kingdon Offshore Master Fund L.P. owns 6.6%, or 1,265,845 shares. Kingdon GP, LLC and Mark Kingdon also own 6.6% and 7.1% respectively. The filing states that all securities reported are directly owned by advisory clients of Kingdon Capital Management, L.L.C., with none of these clients, other than M. Kingdon Offshore Master Fund L.P., owning more than 5% of the Common Stock. The filing was made under Rule 13d-1(c) and includes a joint filing agreement and control person identification.


Tickers mentioned in this filing:NVNO